Early Breast Cancer Detection
October 13, 2009 by drhusbands · Leave a Comment
You probably have heard that breast cancer is the second most common cause of death in women in the U.S. This is reason for concern for women. Early breast cancer detection provides the best outcomes in the event it does occur. Is there something you can do for early breast cancer detection? More importantly, is there a way to detect breast cancer propensity even at the earliest signs? Yes, absolutely. It involves checking your 2:16-hydroxyestrone ratio and having breast thermography.
What is the 2:16 -Hydroxyestrone Ratio?
Estrogens are metabolized in the body by various biochemical pathways. There are large variations among both men and women how estrogens are metabolized. One particular estrogen, called estrone, can be metabolized via the healthy 2-hydroxyestrone (2OH-E1) pathway or the unhealthy 16-α-Hydroxyestrone (16-α-OH-E1) pathway. The ratio by which estrogens are metabolized via these pathways can indicate the long-term risk of developing breast cancer. This ratio is called the 2:16-hydroxyestrone ratio. This ratio is an important indicator for early breast cancer detection and prevention. A ratio of 2 or less means a higher risk for breast cancer. This ratio is also an indicator for other estrogen-sensitive cancers such as ovarian, cervical, uterine, prostate and certain head and neck cancers.
The ratio is accurately, easily and painlessly measured via a special urine test. The test we use to measure this ratio is called the Estronex Test. Surprisingly, many doctors still do not use this valuable test. Contact us at (650) 593-4447 get your Estronex test.
If you take action for early breast cancer detection and find you are at high risk, you can work towards prevention. Research has clearly established that this ratio can be modified by dietary and lifestyle modifications and nutrition supplements. I’ve written about this in previous articles here, here and here.
According to Dr. William Amalu, a breast thermography expert:
The use of Digital Infrared Imaging (DII) is based on the principle that metabolic activity and vascular circulation in both pre-cancerous tissue and the area surrounding a developing breast cancer is almost always higher than in normal breast tissue. In an ever-increasing need for nutrients, cancerous tumors increase circulation to their cells by holding open existing blood vessels, opening dormant vessels, and creating new ones (neoangiogenesis). This process frequently results in an increase in regional surface temperatures of the breast. DII uses ultra-sensitive medical infrared cameras and sophisticated computers to detect, analyze, and produce high-resolution images of these temperature variations. Because of DII’s extreme sensitivity, these temperature variations may be among the earliest signs of breast cancer and/or a pre-cancerous state of the breast 1 2 3 4 5.
Radiation can cause cancer. Unlike mammograms, breast thermography is radiation-free. Breast thermography is more comfortable for women because it does not require squeezing of the breasts. Since DII measures the metabolic activity of cells, and cancer cells are highly metabolically active even when they are of such a small number to be undetectable by mammograms, DII can pick up signs of breast cancer cells earlier than a mammogram. Thus, it is an excellent tool for early breast cancer detection.
Contact us for more information on early breast cancer detection. We also provide the program for modifying your risk of breast cancer.
Dr Husbands is a Chiropractor, a Certified Clinical Nutritionist, an Anti-Aging Healthcare Practitioner and a Functional Medicine Doctor. For more information, visit http://www.drhusbands.com.
- M. Gautherie, Ph.D.; Thermobiological Assessment of Benign and Malignant Breast Diseases. Am. J. Obstet. Gynecol., 1983; V 147, No. 8: 861-869. ↩
- P. Gamigami, M.D.; Atlas of Mammography: New Early Signs in Breast Cancer. Blackwell Science, 1996. ↩
- J. Keyserlingk, M.D.; Time to Reassess the Value of Infrared Breast Imaging? Oncology News Int., 1997; V 6, No. 9. ↩
- P.Ahlgren, M.D., E. Yu, M.D., J. Keyserlingk, M.D.; Is it Time to Reassess the Value of Infrared Breast Imaging? Primary Care & Cancer (NCI), 1998; V 18, No. 2. ↩
- N. Belliveau, M.D., J. Keyserlingk, M.D. et al ; Infrared Imaging of the Breast: Initial Reappraisal Using High-Resolution Digital Technology in 100 Successive Cases of Stage I and II Breast Cancer. Breast Journal, 1998; V 4, No. 4. ↩
